In this on-demand webcast, learn from experts about infections caused by gram-negative extensively drug-resistant organisms (XDROs), including epidemiology associated with antimicrobial resistance and approaches to selecting treatment regimens based on the latest data, patient-specific factors, and pharmacokinetic/pharmacodynamic considerations through challenging clinical cases.
Learn key concepts on gram-negative extensively drug-resistant organism infections, including mechanisms of antibiotic resistance and approaches to selecting treatment regimens based on the latest data, patient-specific factors, and pharmacokinetic/pharmacodynamic considerations.
We are lucky to have multiple options to treat infections caused by KPC-producing bacteria today compared with the suboptimal treatment strategies of the past. But how should we choose among agents empirically?
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.